ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

PLSE Pulse Biosciences Inc

8,12
0,52 (6,84%)
Zuletzt aktualisiert: 19:09:20
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Pulse Biosciences Inc PLSE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,52 6,84% 8,12 19:09:20
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
7,71 7,52 8,13 7,60
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202414:00BWPulse Biosciences Announces Timing of Rights Offering for Up..
24.4.202422:05BWPulse Biosciences Schedules First Quarter 2024 Financial..
28.3.202421:12BWPulse Biosciences Reports Business Updates and Fourth..
28.3.202421:10BWPulse Biosciences Announces Plans to Initiate a Rights..
14.3.202421:05BWPulse Biosciences Schedules Fourth Quarter & Full Year 2023..
11.3.202414:10EDGAR2Form 8-K - Current report
08.3.202419:17BWPulse Biosciences Announces FDA 510(k) Clearance for its..
14.2.202415:22EDGAR2Form 8-K - Current report
14.2.202414:00BWPulse Biosciences Announces Positive 60-Day Follow-Up..
31.1.202414:00BWPulse Biosciences Announces Preliminary Findings from its..
09.1.202415:20EDGAR2Form 8-K - Current report
02.1.202415:20EDGAR2Form 8-K - Current report
02.1.202414:00BWPulse Biosciences Files 510(k) Submission with U.S. FDA for..
22.12.202315:08EDGAR2Form 8-K - Current report
20.12.202315:06EDGAR2Form 8-K - Current report
20.12.202314:00BWPulse Biosciences Announces First-in-Human Procedures with..
27.11.202323:29EDGAR2Form DEF 14A - Other definitive proxy statements
27.11.202315:08EDGAR2Form 8-K - Current report
21.11.202315:03EDGAR2Form 8-K - Current report
21.11.202314:00BWPulse Biosciences Files 510(k) Submission with U.S. FDA for..
17.11.202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202322:05BWPulse Biosciences to Present at the 35th Annual Piper..
13.11.202323:21EDGAR2Form PRE 14A - Other preliminary proxy statements
13.11.202323:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202315:12EDGAR2Form 8-K - Current report
13.11.202314:00BWPulse Biosciences Reports Business Updates and Third Quarter..
10.11.202322:56BWUPDATE Pulse Biosciences Announces New Time for Third..
03.11.202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202321:05BWPulse Biosciences Schedules Third Quarter 2023 Financial..
24.10.202314:00BWPulse Biosciences Appoints Dr. Niv Ad as Chief Science..
02.10.202314:00BWPulse Biosciences Announces Collaboration with CardioNXT for..
29.9.202314:00BWPulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™)..
27.9.202314:00BWPulse Biosciences’ First Study in a Surgical Application of..
12.9.202315:15EDGAR2Form 8-K - Current report
07.9.202322:05BWPulse Biosciences to Present at Gilmartin Group Emerging..
31.8.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
24.8.202322:05BWPulse Biosciences Clarifies Details of Recent S-3 Filing
11.8.202322:49EDGAR2Form S-3 - Registration statement under Securities Act of..
10.8.202322:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202322:14EDGAR2Form 8-K - Current report
10.8.202322:05BWPulse Biosciences Reports Business Updates and Second..
27.7.202322:05BWPulse Biosciences Schedules Second Quarter 2023 Financial..
20.7.202315:25EDGAR2Form 8-K - Current report
15.7.202302:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.7.202302:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.5.202313:00BWPulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™)..
11.5.202322:05BWPulse Biosciences Reports Business Updates and First Quarter..
10.5.202315:29BWPulse Biosciences, Inc. Announces Planned Redemption of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock